Your browser doesn't support javascript.
loading
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients.
Adamo, Annalisa; Frusteri, Cristina; Pilotto, Sara; Caligola, Simone; Belluomini, Lorenzo; Poffe, Ornella; Giacobazzi, Luca; Dusi, Silvia; Musiu, Chiara; Hu, Yushu; Wang, Tian; Rizzini, Davide; Vella, Antonio; Canè, Stefania; Sartori, Giulia; Insolda, Jessica; Sposito, Marco; Incani, Ursula Cesta; Carbone, Carmine; Piro, Geny; Pettinella, Francesca; Qi, Fang; Wang, Dali; Sartoris, Silvia; De Sanctis, Francesco; Scapini, Patrizia; Dusi, Stefano; Cassatella, Marco Antonio; Bria, Emilio; Milella, Michele; Bronte, Vincenzo; Ugel, Stefano.
Afiliación
  • Adamo A; Immunology section, Department of Medicine University and Hospital Trust of Verona, Verona, Italy.
  • Frusteri C; Immunology section, Department of Medicine University and Hospital Trust of Verona, Verona, Italy.
  • Pilotto S; Oncology section, Department of Engineering for Innovative Medicine and Hospital Trust of Verona, Verona, Italy.
  • Caligola S; Veneto Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IOV-IRCCS), Padova, Italy.
  • Belluomini L; Oncology section, Department of Engineering for Innovative Medicine and Hospital Trust of Verona, Verona, Italy.
  • Poffe O; Immunology section, Department of Medicine University and Hospital Trust of Verona, Verona, Italy.
  • Giacobazzi L; Immunology section, Department of Medicine University and Hospital Trust of Verona, Verona, Italy.
  • Dusi S; Veneto Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IOV-IRCCS), Padova, Italy.
  • Musiu C; Immunology section, Department of Medicine University and Hospital Trust of Verona, Verona, Italy.
  • Hu Y; Immunology section, Department of Medicine University and Hospital Trust of Verona, Verona, Italy.
  • Wang T; Immunology section, Department of Medicine University and Hospital Trust of Verona, Verona, Italy.
  • Rizzini D; Immunology section, Department of Medicine University and Hospital Trust of Verona, Verona, Italy.
  • Vella A; Immunology section, Department of Medicine University and Hospital Trust of Verona, Verona, Italy.
  • Canè S; Veneto Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IOV-IRCCS), Padova, Italy.
  • Sartori G; Oncology section, Department of Engineering for Innovative Medicine and Hospital Trust of Verona, Verona, Italy.
  • Insolda J; Oncology section, Department of Engineering for Innovative Medicine and Hospital Trust of Verona, Verona, Italy.
  • Sposito M; Oncology section, Department of Engineering for Innovative Medicine and Hospital Trust of Verona, Verona, Italy.
  • Incani UC; Oncology section, Department of Engineering for Innovative Medicine and Hospital Trust of Verona, Verona, Italy.
  • Carbone C; Medical Oncology, Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy.
  • Piro G; Medical Oncology, Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy.
  • Pettinella F; General Pathology section, Department of Medicine University of Verona, Verona, Italy.
  • Qi F; Department of Burns and Plastic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, P.R. China.
  • Wang D; Department of Burns and Plastic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, P.R. China.
  • Sartoris S; Immunology section, Department of Medicine University and Hospital Trust of Verona, Verona, Italy.
  • De Sanctis F; Immunology section, Department of Medicine University and Hospital Trust of Verona, Verona, Italy.
  • Scapini P; General Pathology section, Department of Medicine University of Verona, Verona, Italy.
  • Dusi S; General Pathology section, Department of Medicine University of Verona, Verona, Italy.
  • Cassatella MA; General Pathology section, Department of Medicine University of Verona, Verona, Italy.
  • Bria E; Veneto Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IOV-IRCCS), Padova, Italy.
  • Milella M; Oncology section, Department of Engineering for Innovative Medicine and Hospital Trust of Verona, Verona, Italy.
  • Bronte V; Veneto Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IOV-IRCCS), Padova, Italy.
  • Ugel S; Immunology section, Department of Medicine University and Hospital Trust of Verona, Verona, Italy.
Oncoimmunology ; 12(1): 2253644, 2023.
Article en En | MEDLINE | ID: mdl-37720688
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Células Supresoras de Origen Mieloide / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Oncoimmunology Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Células Supresoras de Origen Mieloide / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Oncoimmunology Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos